ZYNTEMA
LIVE

Serial Number

79213742

Owner

NOVARTIS AG

Filing Date

Jul 3, 2017

Add to watchlist:

No watchlists yet
View on USPTO

ZYNTEMA Trademark

Serial Number: 79213742 • Registration: 5494573

ZYNTEMA is a trademark filed by NOVARTIS AG on July 3, 2017. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

NOVARTIS AG (7,171 trademarks)

CH-4002
BASEL , CH

Entity Type: 03

Trademark Details

Filing Date

July 3, 2017

Registration Date

June 19, 2018

Published for Opposition

October 31, 2017

Cancellation Date

December 29, 2019

Goods & Services

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculoskeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and the treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma, all of the foregoing excluding pharmaceutical preparations and substances for the treatment or management of sleep disorders"

Filing History

NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Jan 16, 2021 DENC
DEATH OF INTERNATIONAL REGISTRATION
Jan 16, 2021 DETH
FINAL DECISION TRANSACTION PROCESSED BY IB
Sep 21, 2018 FINP
NOTIFICATION PROCESSED BY IB
Aug 17, 2018 GPNX
FINAL DISPOSITION NOTICE SENT TO IB
Jul 24, 2018 FICS
FINAL DISPOSITION PROCESSED
Jul 24, 2018 FIMP
GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Jul 19, 2018 GPAR
REGISTERED-PRINCIPAL REGISTER
Jun 19, 2018 R.PR
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
May 14, 2018 ETOP
POST PUBLICATION AMENDMENT - ENTERED
May 9, 2018 CHPB
ASSIGNED TO PETITION STAFF
May 7, 2018 APET
TEAS POST PUBLICATION AMENDMENT RECEIVED
Apr 23, 2018 EPPA
EXTENSION OF TIME TO OPPOSE RECEIVED
Nov 30, 2017 ETOF
PUBLISHED FOR OPPOSITION
Oct 31, 2017 PUBO
NOTICE OF PUBLICATION
Oct 11, 2017 NPUB
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 15, 2017 CNSA
ASSIGNED TO EXAMINER
Sep 14, 2017 DOCK
UNDELIVERABLE MAIL - NO ACTION TAKEN
Aug 23, 2017 UNDN
APPLICATION FILING RECEIPT MAILED
Aug 11, 2017 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 7, 2017 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Aug 4, 2017 LIMI
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Aug 3, 2017 SDRC